Hohmann Lindsey, Harris Klaudia, Zhao Yi, Marlowe Karen, Phillippe Haley, Correia Chris, Fox Brent
Department of Pharmacy Practice, Harrison College of Pharmacy, Auburn University, 1330 Walker Building, Auburn, AL 36849, USA.
Department of Health Outcomes Research and Policy, Harrison College of Pharmacy, Auburn University, 4306 Walker Building, Auburn, AL 36849, USA.
Pharmacy (Basel). 2023 Jun 11;11(3):99. doi: 10.3390/pharmacy11030099.
The purpose of this study was to explore existing practice models and opportunities surrounding community pharmacist-delivered opioid counseling and naloxone (OCN) services in the U.S., with the goal of enhancing organizational readiness and improving patient access. A scoping literature review was conducted. English-language articles published in peer-reviewed journals from January 2012-July 2022 were sought via PubMed, CINAHL, IPA, and Google Scholar using permutations of terms such as "pharmacist/pharmacy", "opioid/opiate", "naloxone", "counseling", and "implement/implementation". Original articles reporting the resources/inputs (personnel; pharmacist full-time equivalents; facilities and expenses; in-house versus outsourced personnel), implementation processes (legal source of pharmacist authority; patient identification strategies; intervention procedures; workflow strategies; business operations), and programmatic outcomes (uptake and delivery; interventions made; economic impact; patient or provider satisfaction) of pharmacist-delivered OCN services in community (retail) settings were retained. Twelve articles describing ten unique studies were included. The studies primarily used quasi-experimental designs and were published from 2017 to 2021. The articles described seven broad program elements/themes: interprofessional collaboration ( = 2); patient education format including one-on-one patient education ( = 12) and group education sessions ( = 1); non-pharmacist provider education ( = 2); pharmacy staff education ( = 8); opioid misuse screening tools ( = 7); naloxone recommendation/dispensing ( = 12); and opioid therapy and pain management ( = 1). Pharmacists screened/counseled 11-2716 patients and provided 11-430 doses of naloxone. Limited implementation costs, patient/provider satisfaction, or economic impact measures were reported. This review may serve as a guide for community pharmacists in implementing OCN services in their own practices. Future studies should clarify OCN program implementation costs, patient/provider satisfaction, and the economic impact.
本研究的目的是探索美国社区药师提供阿片类药物咨询和纳洛酮(OCN)服务的现有实践模式和机会,以提高组织准备程度并改善患者获得服务的机会。进行了一项范围界定文献综述。通过PubMed、CINAHL、IPA和谷歌学术搜索2012年1月至2022年7月在同行评审期刊上发表的英文文章,使用了“药剂师/药房”、“阿片类药物/鸦片制剂”、“纳洛酮”、“咨询”和“实施”等术语的排列组合。保留了报告社区(零售)环境中药剂师提供OCN服务的资源/投入(人员;药剂师全职等效人员;设施和费用;内部与外包人员)、实施过程(药剂师授权的合法来源;患者识别策略;干预程序;工作流程策略;业务运营)和项目成果(采用和提供;进行的干预;经济影响;患者或提供者满意度)的原始文章。纳入了12篇描述10项独特研究的文章。这些研究主要采用准实验设计,发表于2017年至2021年。文章描述了七个广泛的项目要素/主题:跨专业协作(=2);患者教育形式,包括一对一患者教育(=12)和小组教育课程(=1);非药剂师提供者教育(=2);药房工作人员教育(=8);阿片类药物滥用筛查工具(=7);纳洛酮推荐/配发(=12);以及阿片类药物治疗和疼痛管理(=1)。药剂师筛查/咨询了11至2716名患者,并提供了11至430剂纳洛酮。报告的实施成本、患者/提供者满意度或经济影响措施有限。本综述可作为社区药剂师在其自身实践中实施OCN服务的指南。未来的研究应阐明OCN项目的实施成本、患者/提供者满意度和经济影响。